Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to evaluate the pharmacokinetics of canagliflozin after multiple oral doses of canagliflozin in children and adolescent subjects with T2DM who are 10 to <18 years of age and are currently taking a stable dose of metformin.
Critère d'inclusion
- Patients with type 2 diabetes mellitus (T2DM) on a stable dose of Metformin (receiving standard of care)